intranasal corticosteroids (inss) effectively reduce the nasal inflammation that is a root cause of allergic rhinitis.
鼻腔炎癥是变态反应性鼻炎的根本原因,而鼻内皮质激素能有效减轻鼻腔炎癥。
intranasal corticosteroids may be a promising alternative treatment for patients with rhinitis and mild asthma.
鼻内皮质类固醇可能是合并鼻炎及轻度气喘患者另一种有效的治疗。
they may represent two manifestations of the same united airway disease and therefore intranasal corticosteroids (incs) could improve asthma.
这两种疾病也许代表着同一种气道疾病的两种表现,因此,鼻内类固醇(incs)可改善气喘。
randomised controlled trials comparing intranasal corticosteroids to intranasal placebo or to other traditional asthma treatments were included.
纳入比较鼻内皮质类固醇及鼻内安慰剂或其他传统气喘治疗的随机对照试验。